Wolverine Trading, LLC Teva Pharmaceutical Industries LTD Call Options Transaction History

Wolverine Trading, LLC

$94.2 Billion
Q2 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $322,056 - $438,479	-25,200 Reduced 6.71%	350,200 $5.69 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $1.81 Million - $2.44 Million	169,300 Added 82.14%	375,400 $5.3 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $507,499 - $664,375	-62,500 Reduced 23.27%	206,100 $2.15 Million
Q3 2023 Nov 15, 2023	BUY	$7.48 - $10.7 $437,580 - $625,950	58,500 Added 27.84%	268,600 $2.74 Million
Q2 2023 Aug 23, 2023	BUY	$7.2 - $9.47 $213,120 - $280,312	29,600 Added 16.4%	210,100 $1.58 Million
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $1.02 Million - $1.39 Million	-122,200 Reduced 40.37%	180,500 $1.59 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $460,305 - $548,892	57,900 Added 23.65%	302,700 $2.76 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $274,400 - $478,000	40,000 Added 19.53%	244,800 $1.91 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $580,806 - $818,480	78,700 Added 62.41%	204,800 $1.63 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $984,419 - $1.26 Million	-134,300 Reduced 51.57%	126,100 $1.18 Million
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $936,940 - $1.21 Million	-118,600 Reduced 31.29%	260,400 $2.06 Million
Q3 2021 Nov 12, 2021	BUY	$8.38 - $10.18 $1.39 Million - $1.68 Million	165,300 Added 77.35%	379,000 $3.78 Million
Q2 2021 Aug 06, 2021	BUY	$9.9 - $11.56 $314,820 - $367,608	31,800 Added 17.48%	213,700 $2.14 Million
Q1 2021 May 14, 2021	SELL	$10.34 - $12.81 $3.03 Million - $3.75 Million	-292,600 Reduced 61.66%	181,900 $2.06 Million
Q4 2020 Feb 12, 2021	BUY	$8.61 - $11.04 $2.02 Million - $2.59 Million	234,300 Added 97.54%	474,500 $4.56 Million
Q3 2020 Nov 13, 2020	SELL	$8.57 - $12.69 $490,204 - $725,868	-57,200 Reduced 19.23%	240,200 $2.13 Million
Q2 2020 Aug 13, 2020	SELL	$8.12 - $13.12 $1.22 Million - $1.98 Million	-150,700 Reduced 33.63%	297,400 $3.62 Million
Q1 2020 May 11, 2020	BUY	$6.69 - $13.45 $1.12 Million - $2.24 Million	166,800 Added 59.3%	448,100 $3.81 Million
Q4 2019 Feb 12, 2020	SELL	$6.53 - $10.72 $95,338 - $156,512	-14,600 Reduced 4.93%	281,300 $2.73 Million
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $63,448 - $98,880	-10,300 Reduced 3.36%	295,900 $2.05 Million
Q2 2019 Aug 20, 2019	BUY	$8.12 - $15.72 $1.02 Million - $1.97 Million	125,600 Added 69.55%	306,200 $2.83 Million
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $3.16 Million - $4.06 Million	-203,000 Reduced 52.92%	180,600 $2.83 Million
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $853,515 - $1.39 Million	58,500 Added 17.99%	383,600 $6.02 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $2.38 Million - $2.9 Million	112,900 Added 53.2%	325,100 $7 Million
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $3.54 Million - $4.68 Million	212,200 New	212,200 $3.63 Million
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $3.13 Million - $5.33 Million	-278,900 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$15.41 - $32.17 $4.3 Million - $8.97 Million	278,900	278,900 $4.91 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

565M

Call Options Held

25.2M

Put Options Held

5.08M

Black Rock Inc. New York, NY

43M
Shares

$736 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.3M
Shares

$622 Million
41.14% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

32.3M
Shares

$553 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$493 Million
3.23% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$453 Million
15.49% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account